Goldwind Science And Technology Co., Ltd. Just Missed EPS By 81%: Here's What Analysts Think Will Happen Next

The analysts might have been a bit too bullish on Goldwind Science And Technology Co., Ltd. (SZSE:002202), given that the company fell short of expectations when it released its first-quarter results last week. Results showed a clear earnings miss, with CN¥7.0b revenue coming in 9.6% lower than what the analystsexpected. Statutory earnings per share (EPS) of CN¥0.073 missed the mark badly, arriving some 81% below what was expected. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

Check out our latest analysis for Goldwind Science And Technology

Taking into account the latest results, the current consensus from Goldwind Science And Technology's twelve analysts is for revenues of CN¥55.5b in 2024. This would reflect an okay 7.0% increase on its revenue over the past 12 months. Per-share earnings are expected to leap 577% to CN¥0.50. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥56.5b and earnings per share (EPS) of CN¥0.51 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

It might be a surprise to learn that the consensus price target was broadly unchanged at CN¥8.21, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Goldwind Science And Technology analyst has a price target of CN¥9.18 per share, while the most pessimistic values it at CN¥7.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Goldwind Science And Technology's growth to accelerate, with the forecast 9.4% annualised growth to the end of 2024 ranking favourably alongside historical growth of 6.2% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to see revenue growth of 18% annually. It seems obvious that, while the future growth outlook is brighter than the recent past, Goldwind Science And Technology is expected to grow slower than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Goldwind Science And Technology going out to 2026, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 3 warning signs for Goldwind Science And Technology you should be aware of, and 2 of them are concerning.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.